This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Joachim Rehse
Introduction
Joachim Rehse, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of chemical processes. With a keen focus on synthesizing enantiomerically pure compounds, he has developed a patent that highlights his expertise and innovative thinking.
Latest Patents
Rehse holds a notable patent titled "Process for preparing sodium - Enantiomerically pure sodium 3R,5S-(+)-erythro-(E)-7-4-(4-fluorophenyl)-2,6-diisopropyl-5-methoxy-methyl-pyrid-3-yl!-3,5-dihydroxy-hept-6-enoate." This patent details a sophisticated method for preparing enantiomerically pure compounds through cyclization of racemic esters and subsequent separation via chromatography on a chiral stationary phase. The method culminates in the cleavage of the pure lactones using a base, resulting in the desired enantiomerically pure products.
Career Highlights
Joachim Rehse works at Bayer Aktiengesellschaft, a leading global company in the life sciences sector. His innovative approach and dedication to research have earned him recognition within the industry. The patented process showcases his ability to tackle complex scientific challenges and contribute to advancements in pharmaceutical chemistry.
Collaborations
Throughout his career, Rehse has collaborated with esteemed colleagues, including Rolf Angerbauer and Rolf Grosser. These partnerships have played a pivotal role in developing cutting-edge research and have fostered an environment of innovation within the laboratory.
Conclusion
Joachim Rehse's contributions to the scientific community through his patent and collaborative efforts position him as a notable inventor in the field of chemical processes. His work at Bayer Aktiengesellschaft not only enhances the understanding of enantiomeric synthesis but also reflects the crucial role of collaboration in driving innovation forward.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
